期刊文献+

上下调CD59对宫颈癌细胞增殖活性作用的研究 被引量:2

Up- or down-regulating of CD59 influences Hela cells proliferation
原文传递
导出
摘要 目的探讨上下调CD59锚固蛋白对Hela细胞增殖活性的影响。方法将前期构建的pSUPER-siCD59质粒、pIRES-WT CD59质粒以及增加了CD59W40活性位点(C39W40K41→W39W40W41)的pIRES-MCD59质粒用脂质体转染的方法转染Hela细胞,免疫荧光法倒置荧光显微镜下观察Hela细胞膜上CD59基因表达,并用RT-PCR及Western blot的方法检测各组转染细胞中CD59的表达。采用噻唑蓝(MTT)比色法检测各转染组CD59抗体交联前后Hela细胞增殖活性的变化,比较各组差异。结果转染pSUPER-siCD59质粒组CD59基因与蛋白表达量明显低于正常组,细胞增殖活性降低,而转染pIRES-WT CD59与pIRES-MCD59质粒组则反之。结论下调CD59能抑制Hela细胞增殖活性,上调CD59则能增强其增殖,为宫颈癌的靶向治疗奠定了基础。 The purpose of this study is to observe the changes of Hela cells proliferation induced by up or down regulating of the anchoring protein CD59. By using Lipofectamin 2000, Hela cells were transfected with recombinant pSUPER-siCD59 plasmid, plRES-WTCD59 plasmid, and pIRES-MCD59 plasmid containing CD59's active site W40. Then immunofluorescence, RT-PCR and Western blot were carried out for the detection of CD59 expression both on RNA and protein levels of Hela cells. Subsequently, MTT colorimetry was employed to evaluate the proliferation activity of every Hela cell group. We found that Hela cells transfected with pSUPER-siCD59 plasmid demonstrated lower CD59 expression and lower cell proliferation compared with the normal groups. On the contrary, the groups transfected with pIRES-WTCD59 and plRES-MCD59 plasmids had the opposite effects. The results indicated that down-regulation of CD59 could restrain the proliferation activity of Hela cells, while up- regulation could strengthen it. The study should lay a foundation for the targeted therapy of cervical cancer.
出处 《免疫学杂志》 CAS CSCD 北大核心 2013年第11期943-947,共5页 Immunological Journal
基金 青岛市科技局项目(12-1-3-5-(2)-hsh)
关键词 CD59 上调 下调 HELA细胞 增殖 CD59 Up-regulation Down-regulation Hela cell Proliferation
  • 相关文献

参考文献28

  • 1Geis N,Zell S,Rutz R,et al.Inhibition of membranecomplement inhibitor expression(CD46,CD55,CD59)bysiRNA sensitizes tumor cells to complement attack invitro[J].Current Cancer Drug Targets,2010,10(8):922-931.
  • 2Huang Y,Fedarovich A,Tomlinson S,et al.Crystalstructure of C 1)59:implications for molecular recognition ofthe complement proteins C8 and C9 in the membrane-attack complex[J].Acta Crystallogr D Biol Crystallogr,2007,63(6):714-721.
  • 3Suzuki KG,Kasai RS,Hirosawa KM,et al.Transient GPI-anchored protein homodimers are units for raft organizationand function[J].Nature Chemical Biology,2012,8(9):774-783.
  • 4高美华,秦云,王冰,张蓓,张树超.CD59在T细胞LAT脂筏内移位及跨膜信号转导中的作用[J].免疫学杂志,2013,29(4):301-304. 被引量:5
  • 5Hideshima T,Okada N,Okada H.Expression of HRF20,aregulatory molecule of complement activation,on peripheralblood mononuclear cells[J].Immunology,1990,69(3):396-401.
  • 6Seifert PS,Roth I,Schmiedt W,et al.CD59(homologousrestriction factor 20),a plasma membrane protein thatprotects against complement C5b-9 attack,in humanatherosclerotic lesions[J].Atherosclerosis,1992,96(2/3):135-145.
  • 7Vakeva A,Laurila P,Meri S.Regulation of complementmembrane attack complex formation in myocardialinfarction[J].Am J Pathol,1993,143(1):65-75.
  • 8Seya T,Tejima H,Fukuda H,et al.Acute promyelocyticleukemia with CD59 deficiency[J].Leuk Res,1993,17(10):895-896.
  • 9Weiss L,Okada N,Haeffner Cavaillon N,et al.Decreasedexpression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients[J].AIDS,1992,6(4):379-385.
  • 10Venneker GT,Das PK,Meinardi MM,et al.Glycosylphosphatidylinositol(GPI)-anchored membraneproteins are constitutively down-regulated in psoriaticskin[J].J Pathol,1994,172(2):189-197.

二级参考文献52

  • 1杜瑞琴,白云.CD59的结构与功能关系研究进展[J].免疫学杂志,2000,16(z1):18-23. 被引量:6
  • 2张丽,高美华.突变人CD59基因在真核细胞中的表达活性[J].免疫学杂志,2005,21(4):277-280. 被引量:3
  • 3Ying Cheng Meihua Gao.The Effect of Glycation of CD59 on Complement-Mediated Cytolysis[J].Cellular & Molecular Immunology,2005,2(4):313-317. 被引量:3
  • 4程颖,高美华.利用噬菌体肽库筛选与人CD59特异性结合的短肽[J].细胞与分子免疫学杂志,2006,22(2):164-166. 被引量:11
  • 5Fonsatti E, Ahomonte M, Coral S. Emerging role of protectin (CD59) in humoral immunotherapy of solid malignancies[ J]. Clin Ter, 2000,151(3): 187 -193.
  • 6Fisheison Z, Donin N, Zell S, et al. Obstacles to cancer immunotherapy : expression of membrane complement regulatory proteins (mCRPs) in tumors[J]. Mol Imunol, 2003, 40(2/4) : 109 -123.
  • 7Den C, Fonsatti E, Sigalotti L, et al. Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells [ J ]. J Cell Physiol, 2002, 190 ( 2 ) : 200 - 206.
  • 8Acasta J, Hettinga J, Flllckiger R, et al. Molecular basis for a link between complement and the vascular complications of diabetes [ J ]. Proc Natl Acad Sci USA, 2000, 97(10) : 5450 -5455.
  • 9Ikehara M, Oshita F, Kameda Y, et al. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung[J]. Oncol Rep, 2002, 9(4) : 835 -838.
  • 10Ambrosini G, Adida C, Sirugo G, et al. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting [ J ]. J Biol Chem, 1998, 273(18): 11177-11182.

共引文献25

同被引文献12

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部